Chemotherapeutic agents cell protected from chemotherapy induced. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy9

Cell Line, Tumor Tumor Cells, Cultured Neoplastic Stem Cells HCT116 Cells Cell Line Bone Marrow K562 Cells HL-60 Cells HT29 Cells

Organisms3

Mice, Nude Mice, SCID Mice, Inbred BALB C

Diseases52

Neoplasms Breast Neoplasms Lung Neoplasms Ovarian Neoplasms Adenocarcinoma Brain Neoplasms Carcinoma, Non-Small-Cell Lung Neoplasm Recurrence, Local Neoplasm Metastasis Osteosarcoma Colonic Neoplasms Colorectal Neoplasms Liver Neoplasms Vomiting Bone Neoplasms Pancreatic Neoplasms Lymphoma, Non-Hodgkin Carcinoma Nausea Neoplasms, Experimental Carcinoma, Squamous Cell Neutropenia Stomach Neoplasms Precursor Cell Lymphoblastic Leukemia-Lymphoma Glioma Testicular Neoplasms Leukemia Lymphoma Melanoma Leukemia, Myeloid, Acute Head and Neck Neoplasms Glioblastoma Hodgkin Disease Disease Progression Recurrence Prostatic Neoplasms Neuroblastoma Sarcoma Neoplasms, Germ Cell and Embryonal Lymphatic Metastasis Multiple Myeloma Mucositis Carcinoma, Hepatocellular Leukopenia Thrombocytopenia Medulloblastoma Urinary Bladder Neoplasms Mesothelioma Peritoneal Neoplasms Peripheral Nervous System Diseases Esophageal Neoplasms Neovascularization, Pathologic

Chemicals and Drugs111

Antineoplastic Agents Doxorubicin Cisplatin Etoposide Paclitaxel Cyclophosphamide Antineoplastic Agents, Phytogenic Antibiotics, Antineoplastic Antineoplastic Agents, Alkylating Antimetabolites, Antineoplastic Methotrexate Vinblastine Deoxycytidine Taxoids Carboplatin Bleomycin Dacarbazine Mitomycin Carmustine P-Glycoprotein Camptothecin Fluorouracil Organoplatinum Compounds Cytarabine Daunorubicin Melphalan Lomustine Tumor Suppressor Protein p53 Anthracyclines Ifosfamide Mitoxantrone Proto-Oncogene Proteins c-bcl-2 Vincristine Caspases Thioguanine Thiotepa Neoplasm Proteins RNA, Small Interfering Antibodies, Monoclonal Platinum Antiemetics Apoptosis Regulatory Proteins Antibodies, Monoclonal, Humanized Platinum Compounds Tumor Markers, Biological Noscapine Enzyme Inhibitors Floxuridine bcl-X Protein Alkylating Agents Topotecan Multidrug Resistance-Associated Proteins Poly(ADP-ribose) Polymerases Mitomycins Caspase 3 Nitrosourea Compounds 6-Mercaptopurine Hycanthone Radiation-Sensitizing Agents Tegafur Prodrugs bcl-2-Associated X Protein Tubulin Modulators Drug Carriers RNA, Messenger Nimustine Thymidylate Synthase Angiogenesis Inhibitors Receptor, erbB-2 Cardiotoxins Protein Kinase Inhibitors Quinazolines Tamoxifen Granulocyte Colony-Stimulating Factor Nitrogen Mustard Compounds Arsenicals Dactinomycin Pyrazines Boronic Acids Guanine Tetrazolium Salts Proto-Oncogene Proteins Recombinant Proteins Asparaginase Teniposide TNF-Related Apoptosis-Inducing Ligand Proto-Oncogene Proteins c-akt DNA, Neoplasm Mechlorethamine Bridged Compounds Antiprotozoal Agents Piperazines DNA Topoisomerases, Type II Granisetron Topoisomerase II Inhibitors NF-kappa B ATP-Binding Cassette Transporters Nitroimidazoles Dexamethasone DNA-Binding Proteins Trypanocidal Agents Topoisomerase I Inhibitors Gossypol Isocoumarins Inhibitor of Apoptosis Proteins Prednisolone O(6)-Methylguanine-DNA Methyltransferase Amsacrine Indoles Vindesine Oxides

Analytical, Diagnostic and Therapeutic Techniques and Equipment51

Antineoplastic Combined Chemotherapy Protocols Chemotherapy, Adjuvant Combined Modality Therapy Treatment Outcome Drug Screening Assays, Antitumor Drug Administration Schedule Disease-Free Survival Neoadjuvant Therapy Xenograft Model Antitumor Assays Survival Analysis Neoplasm Staging Prognosis Survival Rate Inhibitory Concentration 50 Neoplasm Transplantation Drug Delivery Systems Clinical Trials as Topic Induction Chemotherapy Salvage Therapy Blotting, Western Drug Evaluation, Preclinical Infusions, Intra-Arterial Transplantation, Heterologous Neoplasms, Experimental Follow-Up Studies Chemotherapy, Cancer, Regional Perfusion Radiotherapy Flow Cytometry Drug Therapy Tumor Burden Transfection Immunohistochemistry Transplantation, Autologous Infusions, Intravenous Radiotherapy, Adjuvant Drug Carriers Reverse Transcriptase Polymerase Chain Reaction Kaplan-Meier Estimate Prospective Studies Tumor Stem Cell Assay Randomized Controlled Trials as Topic Molecular Targeted Therapy Clinical Trials, Phase III as Topic Palliative Care Hematopoietic Stem Cell Transplantation Immunotherapy Radiotherapy Dosage Administration, Oral Hyperthermia, Induced Clinical Trials, Phase II as Topic Drug Evaluation

Phenomena and Processes28

Drug Resistance, Neoplasm Apoptosis Drug Synergism Cell Survival Drug Resistance, Multiple Dose-Response Relationship, Drug Cell Proliferation Time Factors Gene Expression Regulation, Neoplastic Inhibitory Concentration 50 Cell Cycle DNA Damage Drug Resistance Cell Division Cell Death Signal Transduction Transfection Down-Regulation DNA Repair Genes, p53 Drug Interactions Cell Growth Processes Genes, MDR RNA Interference Up-Regulation Enzyme Activation Gene Expression Phosphorylation

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Information Science1

Health Care12

Treatment Outcome Disease-Free Survival Survival Analysis Survival Rate Clinical Trials as Topic Follow-Up Studies Kaplan-Meier Estimate Prospective Studies Randomized Controlled Trials as Topic Clinical Trials, Phase III as Topic Palliative Care Clinical Trials, Phase II as Topic

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Information Science Health Care

Antineoplastic Combined Chemotherapy Protocols Antineoplastic Agents Chemotherapy, Adjuvant Doxorubicin Cisplatin Drug Resistance, Neoplasm Cell Line, Tumor Etoposide Combined Modality Therapy Paclitaxel Cyclophosphamide Apoptosis Antineoplastic Agents, Phytogenic Neoplasms Antibiotics, Antineoplastic Breast Neoplasms Drug Synergism Treatment Outcome Antineoplastic Agents, Alkylating Antimetabolites, Antineoplastic Lung Neoplasms Methotrexate Tumor Cells, Cultured Vinblastine Cell Survival Drug Screening Assays, Antitumor Deoxycytidine Drug Resistance, Multiple Taxoids Dose-Response Relationship, Drug Drug Administration Schedule Carboplatin Disease-Free Survival Bleomycin Neoadjuvant Therapy Dacarbazine Mitomycin Carmustine P-Glycoprotein Xenograft Model Antitumor Assays Camptothecin Survival Analysis Neoplasm Staging Prognosis Mice, Nude Fluorouracil Organoplatinum Compounds Ovarian Neoplasms Cytarabine Survival Rate Daunorubicin Cell Proliferation Melphalan Time Factors Lomustine Tumor Suppressor Protein p53 Anthracyclines Adenocarcinoma Gene Expression Regulation, Neoplastic Ifosfamide Brain Neoplasms Inhibitory Concentration 50 Carcinoma, Non-Small-Cell Lung Mitoxantrone Neoplasm Recurrence, Local Cell Cycle Proto-Oncogene Proteins c-bcl-2 Vincristine Neoplasm Metastasis Osteosarcoma Colonic Neoplasms Colorectal Neoplasms DNA Damage Neoplasm Transplantation Drug Delivery Systems Liver Neoplasms Clinical Trials as Topic Induction Chemotherapy Drug Resistance Caspases Vomiting Bone Neoplasms Thioguanine Cell Division Pancreatic Neoplasms Salvage Therapy Lymphoma, Non-Hodgkin Thiotepa Blotting, Western Neoplasm Proteins Carcinoma Nausea Drug Evaluation, Preclinical Infusions, Intra-Arterial Transplantation, Heterologous Neoplasms, Experimental Follow-Up Studies RNA, Small Interfering Cell Death Chemotherapy, Cancer, Regional Perfusion

No FAQ available that match "chemotherapeutic agents cell protected from chemotherapy induced"